Lantheus Holdings, INC Form 4 insider transactions

NASDAQ
Director Heinz Christoph Maeusli reports acquisition of Lantheus Holdings common stock and stock options.
NASDAQ
Director Gary J. Pruden acquired 2,635 shares of common stock and 4,853 stock options in Lantheus Holdings, Inc. on May 9, 2024.
NASDAQ
Director Sam R. Leno acquired 2,635 shares of common stock and 4,853 stock options in Lantheus Holdings, Inc. on May 9, 2024.
NASDAQ
Julie McHugh, a director at Lantheus Holdings, reported acquiring 2,635 shares of common stock and 4,853 stock options on May 9, 2024.
NASDAQ
Director Mary Anne Heino reports acquisition of shares and stock options in Lantheus Holdings, including transfers from a Grantor Retained Annuity Trust (GRAT).
NASDAQ
Daniel Niedzwiecki, a Chief Administrative Officer, General Counsel, and Corporate Secretary at Lantheus Holdings, Inc., disposed of 177 shares of common stock on April 17, 2024, to cover tax obligations.
NASDAQ
Paul Blanchfield, President of Lantheus Holdings, reports the disposal of 455 shares of common stock to cover tax obligations.
NASDAQ
Andrea Sabens, Chief Accounting Officer of Lantheus Holdings, Inc., reports the sale of 341 shares of common stock at a price of $61.24 per share.
NASDAQ
Robert J. Marshall Jr., CFO and Treasurer of Lantheus Holdings, Inc., sold 20,000 shares of common stock at $60 per share on March 15, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Andrea Sabens, Chief Accounting Officer of Lantheus Holdings, sold 341 shares of common stock at $60.48 per share on March 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Paul Blanchfield, President of Lantheus Holdings, reports the sale and gifting of common stock under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Lantheus Alpha Therapy, a subsidiary of Lantheus Holdings, increases its stake in Perspective Therapeutics through a recent transaction.
NASDAQ
Jean-Claude Provost, Chief Medical Officer of Lantheus Holdings, Inc., reported disposing of 546 shares of common stock on March 5, 2024, for tax purposes.
NASDAQ
Director Sam R. Leno exercised stock options and sold shares of Lantheus Holdings, Inc. under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Robert J. Marshall Jr., CFO and Treasurer of Lantheus Holdings, Inc., disposed of 35,730 shares of common stock on March 5, 2024, to cover tax obligations.
NASDAQ
Etienne Montagut, Chief Business Officer of Lantheus Holdings, disposed of 25,574 shares of common stock to cover tax obligations.
NASDAQ
Andrea Sabens, Chief Accounting Officer of Lantheus Holdings, disposed of 6,360 shares of common stock to cover tax obligations.
NASDAQ
Paul Blanchfield, President of Lantheus Holdings, Inc., disposed of 20,728 shares of common stock on March 5, 2024, to cover tax obligations.
NASDAQ
Daniel Niedzwiecki, a top executive at Lantheus Holdings, disposed of 8,457 shares of common stock on March 5, 2024, to satisfy tax withholding obligations.
NASDAQ
Director Sam R. Leno exercised stock options and sold shares of Lantheus Holdings, Inc. (LNTH) common stock on March 4, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
CFO and Treasurer of Lantheus Holdings, Robert J. Marshall Jr., reports acquisition of common stock and stock options.
NASDAQ
Mary Anne Heino, a director at Lantheus Holdings, reported the acquisition and disposal of common stock on March 4, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Paul Blanchfield, President of Lantheus Holdings, reports acquisition of common stock and stock options, along with adjustments related to performance-based restricted stock units.
NASDAQ
Etienne Montagut, Chief Business Officer of Lantheus Holdings, reports acquisition and disposal of common stock and stock options.
NASDAQ
Jean-Claude Provost, Chief Medical Officer of Lantheus Holdings, reports acquisition of stock options and restricted stock units.
NASDAQ
Daniel Niedzwiecki, a Lantheus Holdings executive, reports the acquisition of common stock and stock options, as well as adjustments related to performance-based restricted stock units (PSUs).
NASDAQ
CEO Brian Markison reports changes in beneficial ownership of Lantheus Holdings stock, including acquisition of restricted stock units and disposal of common stock.
NASDAQ
Andrea Sabens, Chief Accounting Officer of Lantheus Holdings, reports acquisition of common stock and stock options, along with adjustments related to performance-based restricted stock units (PSUs).